Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
The University of Tennessee, Knoxville
160 participants
Mar 1, 2025
INTERVENTIONAL
Conditions
Summary
Participation in regular physical activity is vital to a healthy lifestyle. Research has shown that regular participation in physical activity among cancer survivors is not only able to improve health outcomes, but is also related to their quality of life. As we live in an age of technology, health wearables and smartphone apps might be one novel manner by which to help cancer survivors increase physical activity as well as improve health outcomes. Yet, the effectiveness of wearable and app as a tool for health promotion among cancer survivors is largely unstudied. The purpose of this study is to evaluate the effectiveness of a personalized m-health intervention via fitness wearable (Fitbit Inspire 3) exercise app (sFitRx) on physical activity, weight, quality of life, individual beliefs, and emotions among cancer survivors.
Eligibility
Inclusion Criteria10
- Participant must be at least 18 years of age
- Participant was previously diagnosed with stage 0-III cancer
- Participant have had one or more of the cancers of interest (e.g., breast, lung)
- Participant completed active cancer treatment at least three months prior to enrollment, with the exception of continued maintenance immunotherapy or endocrine therapy
- Participant possess basic English communication capability
- Participant do not participate in other health promotion programs
- Participant is an Android or Apple smartphone owner
- Participant is willing to participate in mHealth-delivered programs
- Participant is willing to consent and be randomized
- Participant has no contraindications to PA participation
Exclusion Criteria10
- Participant is currently undergoing chemotherapy or radiation as primary cancer treatment
- Having any contraindications that might interfere with PA engagement, such as a medical condition and pacemaker implant
- Plan to relocate or travel for >two weeks during the study period;
- Presence of distant metastasis
- Planning or preparing for surgery as primary treatment or as a reconstruction procedure in the next 3 months
- Have a stage 4 cancer diagnosis
- Participant is already engaging in ≥75 min/week of vigorous-intensity PA, ≥150 min/week of moderate-intensity PA, or an equivalent combination of both over the last 3 months
- An unstable mental condition that would prevent following study protocols
- Reporting a Physical Activity Readiness Questionnaire (PAR-Q) score that indicates PA may be unsafe
- Being a prisoner, pregnant, or planning to become pregnant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Experimental Group - Will receive a personalized mHealth application and fitness tracker. Specifically, Experimental Group participants will receive the sFitRx smartphone application that provides weekly personalized PA interventions informed by big data analysis. They will also receive a Fitbit Inspire 3 to track real-time PA, with PA data uploaded to Fitabase. Importantly, the PA data from the Fitbit Inspire 3 will inform the big data analyses used to generate the personalized PA intervention provided by the sFitRx application.
Comparison Group - Will receive the Fitbit Inspire 3 only.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06840028